Making safety a part of drug design

The Global Antibiotic R&D Partnership (GARDP) will host a live webinar with ApconiX’s Dr Claire Sadler on ”Making safety a part of drug design” on 13th November 16.00-17.30 GMT.

 Claire is an expert discovery project toxicologist specialising in early project safety assessment and risk mitigation.  In this webinar, she discusses the toxicological challenges and pitfalls of antibiotic discovery programmes. Potential safety risks are the major reason for terminating a programme in early phases of antibiotic drug development. This webinar will help identifying the most common toxicology risks associated with antibiotic discovery and discuss potential mitigating strategies.

Moderated by Ursula Theuretzbacher, this presentation was part of the recent GARDP and CARB-X co-organized session ‘Antibiotic Bootcamps for Developers: Preclinical Toxicology’ held at the ESCMID/ASM Conference on Drug Development. 

 Please register here to secure your place.

By |2018-11-08T13:12:06+00:00November 2nd, 2018|Events|Comments Off on Making safety a part of drug design

About the Author:

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath Director and Cofounder, ApconiX, UK and Chair and Director of Drug Discovery, University of Birmingham, UK Ruth is chair of drug discovery at Birmingham University, UK and Cofounder of ApconiX, an integrated toxicology and ion channel company that brings together a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development experience. Previously, Ruth was Global Head of Regulatory Safety at AstraZeneca and Director of Toxicology for Aventis. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development. With >140 publications in peer reviewed journals, she is focused on reducing attrition attributable to safety and toxicity. A former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and president elect of the Academy of Toxicological Sciences, Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology.